TanshinoneII A CAS: 568-72-9

CAS NO: 568-72-9
TanshinoneII A
Write an article on TanshinoneII A CAS: 568-72-9
Introduce this product
Chemical name
Molecular formula
Formula weight
CAS No
find top ten keywords from google and Synonyms
Health benefits of this product
Potential effects
Product
Description Review
Description

Tanshinone II A is a natural compound found in the roots of Salvia miltiorrhiza, also known as Danshen. Its chemical name is 1,6,6-trimethyl-7-oxabicyclo [2.2.1] heptan-2-one and its molecular formula is C19H18O3, with a molecular weight of 294.35 g/mol. The CAS number for tanshinone II A is 568-72-9.

Top Ten Keywords and Synonyms:

  1. Tanshinone II A extract
  2. Salvia miltiorrhiza extract
  3. Antioxidant properties
  4. Anti-inflammatory effects
  5. Cardiovascular benefits
  6. Neuroprotective effects
  7. Anticancer activity
  8. Dan-shen ketone
  9. Tan IIA
  10. Cryptotanshinone

Health Benefits of Tanshinone II A: Tanshinone II A has been used in traditional Chinese medicine for its various health benefits. Recent studies have shown that it possesses antioxidant, anti-inflammatory, cardiovascular, neuroprotective and anticancer properties.

  1. Antioxidant Properties: Tanshinone II A has potent antioxidant properties which help to scavenge free radicals and reduce oxidative stress in cells. These properties make it a potential therapeutic agent for various chronic diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases.

  2. Anti-inflammatory Effects: Tanshinone II A exerts an anti-inflammatory effect by inhibiting the expression of pro-inflammatory cytokines and enzymes such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and cyclooxygenase-2 (COX-2). This makes it a potential treatment for inflammatory diseases such as rheumatoid arthritis and asthma.

  3. Cardiovascular Benefits: Tanshinone II A has beneficial effects on the cardiovascular system by reducing blood pressure, improving endothelial function and preventing platelet aggregation. These properties make it a potential treatment for hypertension, atherosclerosis, and other cardiovascular diseases.

  4. Neuroprotective Effects: Tanshinone II A has neuroprotective effects by inhibiting oxidative stress, reducing inflammation and reducing neuronal apoptosis. These properties make it a potential therapy for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

  5. Anticancer Activity: Tanshinone II A has been found to possess anticancer activity by inhibiting cell proliferation, inducing cell cycle arrest and promoting apoptosis in various cancer cells. It has been studied for its potential use in treating cancers of the breast, lung, colon and liver.

Product Mechanism: The therapeutic effects of Tanshinone II A are thought to be mediated through several mechanisms. It activates the Nrf2 pathway which regulates antioxidant and cytoprotective gene expression. It also modulates various signaling pathways involved in inflammation, oxidative stress, and apoptosis. Tanshinone II A inhibits the activation of NF-κB, a transcription factor that plays a key role in regulating the expression of genes involved in inflammation and immune responses.

Safety and Side Effects: Tanshinone II A is generally considered safe when used as directed. However, high doses or prolonged use may cause gastrointestinal upset, headache and dizziness. It is also known to interact with certain medications such as anticoagulants, antiplatelets, and chemotherapy agents.

Dosing Information: There is no standard dosing for tanshinone II A because it depends on the condition being treated. However, typical doses range from 50 to 200 mg per day, taken orally.

In Conclusion: Tanshinone II A is a natural compound with promising therapeutic potential. Its antioxidant, anti-inflammatory, cardiovascular, neuroprotective and anticancer properties make it a valuable candidate for the development of new drugs. However, more research is needed to determine its efficacy, safety, and optimal dosing in humans. As with any dietary supplement, it is important to consult a healthcare professional before taking tanshinone II A

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code